Literature DB >> 9730725

Hemolytic uremic syndrome associated with beta-interferon therapy for chronic hepatitis C.

Y Ubara, S Hara, H Takedatu, H Katori, K Yamada, K Yoshihara, Y Matsushita, K Yokoyama, F Takemoto, A Yamada, R Takagawa, Y Endo, M Hara, I Koida, H Kumada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9730725     DOI： 10.1159/000045147

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  10 in total

Review 1.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Thrombotic microangiopathy associated with use of interferon-beta.

Authors:  Teresa Olea; Raquel Díaz-Mancebo; Maria-Luz Picazo; Jorge Martínez-Ara; Angel Robles; Rafael Selgas
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-06-15

3.  Acute renal failure, systemic lupus erythematosus and thrombotic microangiopathy following treatment with beta-interferon for multiple sclerosis: case report and review of the literature.

Authors:  Thomas Hansen; David New; Roy Reeve; Rosemary Donne; William Stephens
Journal:  NDT Plus       Date:  2009-09-22

4.  Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis.

Authors:  Julien Mahe; Aurélie Meurette; Anne Moreau; Caroline Vercel; Pascale Jolliet
Journal:  Drug Des Devel Ther       Date:  2013-08-07       Impact factor: 4.162

5.  Thrombotic Microangiopathy in Interferon-beta-Treated Multiple Sclerosis Patient.

Authors:  Masoud Mohammad Malekzadeh; Reza Alizadeh; Ziba Aghsaeifard; Mohammad Ali Sahraian
Journal:  Clin Case Rep       Date:  2020-03-30

6.  Broad spectrum of interferon-related nephropathies-glomerulonephritis, systemic lupus erythematosus-like syndrome and thrombotic microangiopathy: A case report and review of literature.

Authors:  Iacopo Gianassi; Marco Allinovi; Leonardo Caroti; Lino Calogero Cirami
Journal:  World J Nephrol       Date:  2019-11-12

7.  Interferon-β1a-Induced Thrombotic Microangiopathy: Possible Implication of the Alternative Pathway of the Complement.

Authors:  Maxime Taghavi; Patrick Stordeur; Frédéric Collart; Bernard Dachy; Agnieszka Pozdzik; Maria Do Carmo Filomena Mesquita; Joëlle Nortier
Journal:  Kidney Int Rep       Date:  2022-05-13

Review 8.  Atypical hemolytic uremic syndrome.

Authors:  David Kavanagh; Tim H Goodship; Anna Richards
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

9.  Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab.

Authors:  Marco Allinovi; Calogero Lino Cirami; Leonardo Caroti; Giulia Antognoli; Silvia Farsetti; Maria Pia Amato; Enrico Eugenio Minetti
Journal:  Clin Kidney J       Date:  2017-02-16

10.  Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature review.

Authors:  Maxime Dauvergne; David Buob; Cédric Rafat; Marie-Flore Hennino; Mathilde Lemoine; Vincent Audard; Dominique Chauveau; David Ribes; Emilie Cornec-Le Gall; Eric Daugas; Evangéline Pillebout; Vincent Vuiblet; Jean-Jacques Boffa
Journal:  Clin Kidney J       Date:  2021-07-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.